Who Owns Maze Therapeutics, Inc. (MAZE)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$InfinityT
% of Float Held
3.2875790188079185e+284%
QoQ Change in Holders
+9 / -6
Price History
MAZE — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | +2.4M | +$110.5B |
| Bellevue Group AG | New Position | +888K | +$36.8B |
| VR Adviser, LLC | Increased | +318K | +$32.2B |
| FMR LLC | Increased | +73K | +$29.0B |
| Caligan Partners LP | New Position | +550K | +$22.8B |
| CITADEL ADVISORS LLC | New Position | +448K | +$18.0B |
| ArrowMark Colorado Holdings LLC | Increased | +222K | +$17.7B |
| EVENTIDE ASSET MANAGEMENT, LLC | New Position | +324K | +$13.4B |
| WASHINGTON UNIVERSITY | New Position | +281K | +$11.6B |
| TCG Crossover Management, LLC | New Position | +174K | +$7.2B |
| HighVista Strategies LLC | New Position | +170K | +$7.0B |
| ADAR1 Capital Management, LLC | Increased | +153K | +$6.8B |
| MILLENNIUM MANAGEMENT LLC | New Position | +154K | +$6.0B |
| STEMPOINT CAPITAL LP | New Position | +126K | +$5.2B |
| Ensign Peak Advisors, Inc | Increased | +115K | +$5.2B |
MAZE — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| TRV GP IV, LLC | Decreased | -1.6M | -$157.3B |
| Matrix Capital Management Company, LP | Decreased | -1.2M | -$42.9B |
| General Catalyst Group Management, LLC | Closed Position | -1.0M | -$26.9B |
| Ikarian Capital, LLC | Decreased | -96K | -$19.2B |
| Alphabet Inc. | Decreased | -1.0M | -$5.0B |
| Octagon Capital Advisors LP | Closed Position | -178K | -$4.6B |
| BALYASNY ASSET MANAGEMENT L.P. | Decreased | -235K | -$3.2B |
| Schonfeld Strategic Advisors LLC | Decreased | -66K | -$3.0B |
| Nantahala Capital Management, LLC | Closed Position | -93K | -$2.4B |
| HARVARD MANAGEMENT CO INC | Closed Position | -92K | -$2.4B |
| RENAISSANCE TECHNOLOGIES LLC | Decreased | -59K | -$1.2B |
| ALLIANCEBERNSTEIN L.P. | Decreased | -27K | -$558.4M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Closed Position | -16K | -$419.2M |
| WINTON GROUP Ltd | Closed Position | -14K | -$375.6M |
| TWO SIGMA INVESTMENTS, LP | Decreased | -4K | -$289.1M |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 4,567,274 | $189.2B | 5.08% | Share |
| 2 | ARCH Venture Management, LLC | 4,120,053 | $170.7B | 26.19% | Share |
| 3 | JANUS HENDERSON GROUP PLC | 3,142,587 | $130.0B | 0.06% | Share |
| 4 | VR Adviser, LLC | 1,548,569 | $64.2B | 3.17% | Share |
| 5 | Alphabet Inc. | 1,388,583 | $57.5B | 2.23% | Share |
| 6 | Woodline Partners LP | 1,035,229 | $42.0B | 0.16% | Share |
| 7 | TRV GP V, LLC | 950,800 | $39.4B | 9.18% | Share |
| 8 | Logos Global Management LP | 950,000 | $39.4B | 2.38% | Share |
| 9 | Bellevue Group AG | 887,708 | $36.8B | 0.70% | Share |
| 10 | ArrowMark Colorado Holdings LLC | 767,383 | $31.8B | 0.70% | Share |
| 11 | Casdin Capital, LLC | 758,857 | $31.4B | 1.95% | Share |
| 12 | FMR LLC | 588,156 | $24.0B | 0.00% | Share |
| 13 | Caligan Partners LP | 550,191 | $22.8B | 1.88% | Share |
| 14 | Foresite Capital Management IV, LLC | 522,657 | $21.7B | 9.43% | Share |
| 15 | HHLR ADVISORS, LTD. | 457,535 | $19.0B | 0.61% | Share |
| 16 | CITADEL ADVISORS LLC | 448,217 | $18.0B | 0.00% | Share |
| 17 | DRIEHAUS CAPITAL MANAGEMENT LLC | 378,015 | $15.7B | 0.11% | Share |
| 18 | EVENTIDE ASSET MANAGEMENT, LLC | 324,041 | $13.4B | 0.21% | Share |
| 19 | WASHINGTON UNIVERSITY | 280,802 | $11.6B | 5.88% | Share |
| 20 | BALYASNY ASSET MANAGEMENT L.P. | 199,212 | $8.0B | 0.01% | Share |
| 21 | Alyeska Investment Group, L.P. | 196,124 | $8.0B | 0.02% | Share |
| 22 | ADAR1 Capital Management, LLC | 179,532 | $7.4B | 0.54% | Share |
| 23 | TCG Crossover Management, LLC | 173,816 | $7.2B | 0.24% | Share |
| 24 | Ensign Peak Advisors, Inc | 185,794 | $7.0B | 0.01% | Share |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 175,969 | $7.0B | 0.00% | Share |
| 26 | NORTHERN TRUST CORP | 172,721 | $7.0B | 0.00% | Share |
| 27 | HighVista Strategies LLC | 170,353 | $7.0B | 1.80% | Share |
| 28 | MILLENNIUM MANAGEMENT LLC | 154,470 | $6.0B | 0.00% | Share |
| 29 | STEMPOINT CAPITAL LP | 125,877 | $5.2B | 0.89% | Share |
| 30 | FMR LLC | 140,449 | $5.0B | 0.00% | Share |
| 31 | Invesco Ltd. | 114,655 | $4.8B | 0.00% | Share |
| 32 | Integral Health Asset Management, LLC | 100,000 | $4.1B | 0.21% | Share |
| 33 | AMERIPRISE FINANCIAL INC | 96,688 | $4.0B | 0.00% | Share |
| 34 | GOLDMAN SACHS GROUP INC | 106,145 | $4.0B | 0.00% | Share |
| 35 | Freestone Grove Partners LP | 118,876 | $4.0B | 0.03% | Share |
| 36 | SummitTX Capital, L.P. | 69,560 | $2.9B | 0.09% | Share |
| 37 | OSAIC HOLDINGS, INC. | 59,762 | $2.0B | 0.00% | Share |
| 38 | RAYMOND JAMES FINANCIAL INC | 66,447 | $2.0B | 0.00% | Share |
| 39 | Nuveen, LLC | 51,590 | $2.0B | 0.00% | Share |
| 40 | FRANKLIN RESOURCES INC | 52,640 | $2.0B | 0.00% | Share |
| 41 | Cinctive Capital Management LP | 29,134 | $1.2B | 0.07% | Share |
| 42 | UBS Group AG | 28,453 | $1.2B | 0.00% | Share |
| 43 | WELLINGTON MANAGEMENT GROUP LLP | 41,013 | $1.0B | 0.00% | Share |
| 44 | AQR CAPITAL MANAGEMENT LLC | 26,854 | $1.0B | 0.00% | Share |
| 45 | XTX Topco Ltd | 33,021 | $1.0B | 0.03% | Share |
| 46 | ALLIANCEBERNSTEIN L.P. | 33,220 | $1.0B | 0.00% | Share |
| 47 | RENAISSANCE TECHNOLOGIES LLC | 27,100 | $1.0B | 0.00% | Share |
| 48 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 31,295 | $1.0B | 0.00% | Share |
| 49 | BARCLAYS PLC | 39,508 | $1.0B | 0.00% | Share |
| 50 | GILDER GAGNON HOWE & CO LLC | 23,282 | $964.0M | 0.01% | Share |
MAZE Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 141 | $1.1T | +60 |
| Q3 2025 | 81 | $824.0B | +17 |
| Q2 2025 | 64 | $395.7B | -4 |
| Q1 2025 | 68 | $395.8B | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold MAZE (Maze Therapeutics, Inc.). The largest holder is Frazier Life Sciences Management, L.P. with $189.2B in shares. This quarter, 9 institutions opened new positions and 6 closed their positions.
Frequently Asked Questions
How many hedge funds own MAZE?
As of Q4 2025, 50 institutional investors report holding MAZE (Maze Therapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of MAZE?
The largest institutional holder of MAZE is Frazier Life Sciences Management, L.P. with $189.2B in shares.
Is institutional ownership of MAZE increasing or decreasing?
This quarter, 9 institutions opened new positions in MAZE and 6 closed their positions.